Vitrolife Ab Stock Five Year Return
| VITR Stock | SEK 225.20 0.40 0.18% |
Vitrolife AB fundamentals help investors to digest information that contributes to Vitrolife's financial success or failures. It also enables traders to predict the movement of Vitrolife Stock. The fundamental analysis module provides a way to measure Vitrolife's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Vitrolife stock.
Vitrolife |
Vitrolife AB Company Five Year Return Analysis
Vitrolife's Five Year Return is considered one of the best measures to evaluate fund performance, especially from the mid and long term perspective. It shows the total annualized return generated from holding equity for the last five years and represents capital appreciation of the investment, including all dividends, losses, and capital gains distributions.
More About Five Year Return | All Equity Analysis
Five Year Return | = | (Mean of Monthly Returns - 1) | X | 100% |
Current Vitrolife Five Year Return | 0.56 % |
Most of Vitrolife's fundamental indicators, such as Five Year Return, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Vitrolife AB is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Although Five Year Returns can give a sense of overall investment potential, it is recommended to compare equity performance with similar assets for the same five year time interval. Similarly, comparing overall investment performance over the last five years with the appropriate market index is a great way to determine how this equity instrument will perform during unforeseen market fluctuations.
| Competition |
According to the company disclosure, Vitrolife AB has a Five Year Return of 0.56%. This is much higher than that of the Biotechnology sector and significantly higher than that of the Health Care industry. The five year return for all Sweden stocks is notably lower than that of the firm.
Did you try this?
Run Portfolio Center Now
Portfolio CenterAll portfolio management and optimization tools to improve performance of your portfolios |
| All Next | Launch Module |
Vitrolife Fundamentals
| Return On Equity | 0.0246 | |||
| Return On Asset | 0.0205 | |||
| Profit Margin | 0.12 % | |||
| Operating Margin | 0.20 % | |||
| Current Valuation | 28.19 B | |||
| Shares Outstanding | 135.45 M | |||
| Shares Owned By Insiders | 32.02 % | |||
| Shares Owned By Institutions | 43.80 % | |||
| Price To Earning | 58.44 X | |||
| Price To Book | 1.61 X | |||
| Price To Sales | 8.73 X | |||
| Revenue | 1.68 B | |||
| Gross Profit | 1.78 B | |||
| EBITDA | 576.66 M | |||
| Net Income | 340.97 M | |||
| Cash And Equivalents | 630.09 M | |||
| Cash Per Share | 4.11 X | |||
| Total Debt | 2.03 B | |||
| Debt To Equity | 4.90 % | |||
| Current Ratio | 4.79 X | |||
| Book Value Per Share | 123.61 X | |||
| Cash Flow From Operations | 384.31 M | |||
| Earnings Per Share | 2.57 X | |||
| Price To Earnings To Growth | 3.50 X | |||
| Target Price | 335.0 | |||
| Number Of Employees | 1.07 K | |||
| Beta | 1.49 | |||
| Market Capitalization | 31.97 B | |||
| Total Asset | 19.43 B | |||
| Retained Earnings | 390 M | |||
| Working Capital | 327 M | |||
| Current Asset | 467 M | |||
| Current Liabilities | 140 M | |||
| Z Score | 9.0 | |||
| Annual Yield | 0 % | |||
| Five Year Return | 0.56 % | |||
| Net Asset | 19.43 B | |||
| Last Dividend Paid | 0.85 |
About Vitrolife Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Vitrolife AB's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Vitrolife using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Vitrolife AB based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Vitrolife Stock Analysis
When running Vitrolife's price analysis, check to measure Vitrolife's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vitrolife is operating at the current time. Most of Vitrolife's value examination focuses on studying past and present price action to predict the probability of Vitrolife's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vitrolife's price. Additionally, you may evaluate how the addition of Vitrolife to your portfolios can decrease your overall portfolio volatility.